Quality Ingredients

Backed by experts and people who care about you and your pets

A dietary supplement for joint health born from research.

"In purchasing dietary supplements, I've learned to be careful of what I buy. Things are not always delivered as they are advertised.With Myristin®, you can be confident that you are getting the real cetyl myristoleate that I discovered and researched."
- Harry W. Diehl, Ph.D.

Drug-Free Ingredients

Cetyl Myristoleate (CMO) supplements can be found in several forms such as soft gels, capsules, and cream. Our formulas are a non-narcotic drug-free alternative to managing joint pain. Our products contain the highest concentration of CMO in the world that are commercially available. Myristin® is made exclusively in the USA.

As the family company of Harry W. Diehl, Ph.D., the discoverer of Cetyl Myristoleate, Myristin® is determined to offer the highest quality CMO products at exceptional pricing. We encourage customers to compare any competing product's price and volume of molecular CMO to Myristin®’s.

Our product adheres to FDA regulations which require that we report accurate information regarding our ingredients. CMO has been researched since 1964. The research articles, which include publications in peer reviewed journals, can be located through our site.

Read all about their tremendous results.


For People

Made with the strongest concentration of Cetyl Myristoleate (CMO) of any product in the world for fast, powerful relief. Options for various needs and absorption aid to help you get the most benefit from Myristin®.

Shop Myristin® for People
For Pets

Designed for dogs, cats, and other small pets. The chewable tablets contain Cetyl Myristoleate (CMO) and Glucosamine Sulfate and Methylsulfonylmethane (MSM) to help your loved ones feel their best!

Shop Myristin® for Pets
For Horses

We're working on a brand new option to fit the needs of horse owners and caretakers, a supplement that specializes in Cetyl Myristoleate (CMO) in a format horses will love, at the best value.

Coming Soon! (2023)